Meeder Asset Management Inc Krystal Biotech, Inc. Transaction History

Meeder Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 02, 2020	SELL	$37.76 - $48.49 $18,917 - $24,293	-501 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$35.02 - $65.64 $40,868 - $76,601	-1,167 Reduced 69.96%	501 $21,000
Q4 2019 Feb 13, 2020	BUY	$33.17 - $65.23 $47,134 - $92,691	1,421 Added 575.3%	1,668 $93,000
Q3 2019 Oct 17, 2019	BUY	$34.72 - $51.3 $8,575 - $12,671	247 New	247 $8,000

275

24.9M

270K

172K

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $4.54B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.